Today: 9 June 2026
AmpliTech Jumps on 5G Win, Eyes North America Sales
20 May 2026
2 mins read

AmpliTech Jumps on 5G Win, Eyes North America Sales

Hauppauge, New York, May 20, 2026, 09:05 EDT

  • AmpliTech said its full indoor 5G Native DAS hardware stack is now certified by regulators in both the U.S. and Canada.
  • The company said it can begin commercial sales, shipping, and network integration in North America immediately.
  • AMPG shares jumped about 14% in premarket trading after the announcement.

AmpliTech Group shares rose before the bell Wednesday after it said its full indoor 5G Native Distributed Antenna System, or DAS, got approval in the U.S. and Canada. The system aims to boost wireless coverage inside buildings.

AmpliTech said it has secured approvals from both the FCC and ISED Canada for its 5G Pico Radio, AC and DC Mother Hubs, and Cascading Hubs. With these certifications, AmpliTech can now sell, ship, and integrate its system across the U.S. and Canada.

AmpliTech said it’s moving into full 5G infrastructure systems, expanding from its component roots. Shares gained about 14% before the market opened, according to Investing.com. Nasdaq had not opened yet.

AmpliTech rolled out a new product for Fixed Wireless Access (FWA) and Private 5G, the company said. FWA brings broadband over wireless, not fiber. Private 5G covers places like factories, logistics centers, military bases, and hospitals. AmpliTech says its system pushes 5G over thousands of feet.

AmpliTech CEO and CTO Fawad Maqbool said new approvals are “one of the most significant technical and operational milestones” for AmpliTech. Maqbool said the company is moving past standalone radios and is now aiming at an “end-to-end infrastructure solution.” GlobeNewswire

AmpliTech has secured orders for its product suite from a North American mobile network operator, according to Maqbool. Shipments should begin later this year. The company hasn’t named the customer or disclosed the deal’s value.

AmpliTech released its update a week after reporting first-quarter revenue up 48.6% to $5.35 million from a year ago. Gross margin improved to 48.0%, up from 33.0%. Net loss narrowed to $1.52 million, compared with $1.84 million, a company filing showed.

AmpliTech’s most recent balance sheet gives the small-cap a bit of room. The company said it held $11.8 million in cash and equivalents and had $6.6 million in marketable securities as of March 31, according to its latest quarter. Working capital was $25.4 million. The accumulated deficit hit $29.5 million.

AmpliTech’s latest certification puts it in the mix with other communications-equipment firms, where customers weigh price, compatibility, and reliability. StockTitan’s market screen noted Ceragon Networks and Inseego moving up along with AMPG, suggesting some action among small telecom-equipment names, but AmpliTech’s move followed its own certification news.

Open RAN, or Open Radio Access Network, is designed to let hardware from multiple suppliers work together through open specs. AmpliTech said its Native DAS connects Open RAN equipment inside one vendor’s setup. This could help integrators by making the system less complicated to install.

AmpliTech faces some big hurdles. Certification alone won’t bring in large contracts. The company is losing money. In filings, AmpliTech warns its plans could fall short, pointing to supply-chain problems and uncertainty over market demand for O-RAN as main risks.

Maqbool described the quarter as “meaningful progress” during last week’s earnings call. The company held its full-year revenue forecast and said it expects more revenue in the back half of the year. Investors are watching to see if today’s regulatory clearance results in shipments and actual cash flow as planned.

Stock Market Today

  • S&P 500 Rallies on Chipmaker Gains; Crude Oil Prices Retreat After Iran-Israel Ceasefire Signal
    June 9, 2026, 9:24 AM EDT. The S&P 500 gained +0.30% on Monday, driven by renewed investor interest in artificial intelligence boosting chipmakers. Nasdaq 100 rose +1.58%, while the Dow slipped -0.16%, dragged lower by Apple's -1% drop amid lukewarm AI platform feedback. Crude oil prices surged over +4% initially due to Iran-Israel tensions but retreated after Iran signaled an end to its current military operation. The market discounts a low 3% chance of a +25 basis point rate hike by the Federal Reserve on June 16-17. Treasury yields climbed, with 10-year notes reaching a two-week high of 4.58%, pressured by strong US jobs data and heavy upcoming Treasury auctions. Overseas markets closed mixed, with China's Shanghai Composite down -1.70% and Japan's Nikkei falling -3.85%.

Latest articles

IREN Stock Approaches $60 as AI Data-Center Bet Hits Key Point

IREN Stock Approaches $60 as AI Data-Center Bet Hits Key Point

9 June 2026
IREN surged 8.9% to $59.19 and was quoted higher premarket after a bitcoin rebound and renewed focus on its pivot to AI cloud infrastructure, but the stock remains exposed to bitcoin swings, heavy spending, and risks tied to its new 800MW South Australia data center project and major contracts with Nvidia and Microsoft.
AT&T Moves Higher Pre-Market on $45 Billion Payout Plan Still in Focus

AT&T Moves Higher Pre-Market on $45 Billion Payout Plan Still in Focus

9 June 2026
AT&T shares edged up to $22.58 pre-market after reaffirming 2026 guidance and a $45B+ shareholder return plan, providing a cash-flow marker as satellite broadband competition looms; the stock remains pressured by SpaceX risks flagged by Oppenheimer, with second-quarter free cash flow seen at $4.0–$4.5B.
GSK’s $10.6 Billion Oncology Leap Goes Deeper Than Headlines Show

GSK’s $10.6 Billion Oncology Leap Goes Deeper Than Headlines Show

9 June 2026
GSK will buy Nuvalent for $10.6 billion in cash, paying a 40% premium, to boost its oncology pipeline ahead of looming HIV drug patent expiries; Nuvalent shares jumped 38.9% premarket while GSK fell 1.4%, with the deal expected to add to GSK sales and profit from 2027 but dilute earnings per share 2026-2028 if it closes in Q3, and final outcome depends on FDA approvals and regulatory clearance.
AmpliTech’s 5G Radio Test Moves AMPG Shares

AmpliTech’s 5G Radio Test Moves AMPG Shares

9 June 2026
AMPG soared 26.7% to $6.57 after AmpliTech revealed its 64T64R Massive MIMO radio was the only one of its kind at O-RAN PlugFest, showing interoperability with major carriers’ equipment, but no new orders were announced, leaving sales conversion as the key investor focus.
Cartesian Growth Ticker Change Draws Trader Attention to Factorial Energy

Cartesian Growth Ticker Change Draws Trader Attention to Factorial Energy

9 June 2026
Factorial Energy surged 16% to $13.80 in its Nasdaq debut as FAC, with premarket trading near $20.70, after replacing CGCT via SPAC merger that raised over $100 million for battery commercialization and implied a $1.3 billion equity value; former CGCT shares now trade as FAC, with founders retaining majority voting power and staged lock-up releases ahead.
Intuit’s Q3 Numbers Land as Shares Down 39%
Previous Story

Intuit’s Q3 Numbers Land as Shares Down 39%

ImmunityBio in the Spotlight with Patents and BCG Deal Ahead of the Open
Next Story

ImmunityBio Faces FDA Decision on Bladder-Cancer Application, Risk Remains

Go toTop